Using Technology to Improve Quality of Care
We are a team of Doctors, Engineers, Nutritional Scientists and Physiologists, that have come together to address some of most common challenges in modern healthcare. We all share a passion for helping patients in need of major medical intervention to maintain quality of life throughout their treatment journey.
We believe a major medical intervention such as cancer or surgery should not automatically result in reduced quality of life. Our programs are designed with the needs of patients in mind. Our pathways are proven to result in significant overall improvements in health-related quality of life for patients
Professor Tara Rampal, MBBS FRCA
FOUNDER AND MANAGING DIRECTOR
Professor Rampal is a Consultant Anaesthetist with a keen interest in Peri-Operative care and Population Health. She trained at the Barts and the London School of Anaesthesia where she was awarded the Excellence Award for Academic Achievement in 2008. Professor Rampal has a credible and commendable track record of developing world-class award-winning patient optimisation services. During her tenure at Medway NHS Foundation Trust (MFT) she led the development of the Prehab Unit. For her work, she received Enhance Recovery After Surgery Society (ERAS) award for the best perioperative success story (2019) as well as Chief Executive’s Scholarship for Brilliance. The latter facilitated her travel and observership of the prehab unit at McGill University in Montreal. While she led the Prehab Unit at MFT, the unit was rated outstanding by the Care Quality Commission (CQC) inspection of the Trust (2020) and featured on the BBC South East news (2020). She subsequently founded and leads the award-winning Kent and Medway Prehab™ programme, a pan-county multi-organisation collaborative helping cancer patients to get fitter through targeted physical and psychological support. It is supported by Public Health and Cancer Alliance. This programme was featured as a case study in the NHS-X digital playbook. She has completed the Leadership in Population Health module at the King’s Fund London and is a visiting Professor at the University of Greenwich.
Dr Nick Plowman, MA, MD, FRCR, FRCP
Dr. Plowman has been a Consultant Oncologist at St. Bartholomew’s Hospital and the Hospital for Sick Children in London for thirty-years. His research work has led to advances in medical practice worldwide including the introduction of aromatase inhibitors into breast cancer management and glucocorticoids into advanced prostate cancer management.
Mr Nathan Nagel is a life science/clinical entrepreneur with 23 years’ experience of which 12 years’ experience of being an executive director. His past executive experience includes CEO at Gamlen Tableting Ltd (Pharmaceuticals), Managing Director of Sanyal Bio LLC (Liver disease), and Managing partner of Life Science Ventures Ltd (Healthcare Venture Capital).
Advisor and director with focus on Technology and Real Estate. Chairman of the Board at Bonäsudden Holding AB (Publ) and Board Member at Sydsvenska Hem AB (Publ). Leader with successful track record in building and managing organisations in dynamic and fast growing start-up environments as well as corporations. Karl holds a Master of Science degree from in Chemical Engineering Chalmers University of Technology in Sweden.